Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023

Saved in:
Bibliographic Details
Published in:MMWR Morbidity and Mortality Weekly Report
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030188965199876
collection WordPress RSS
FRELIP Feed Integration
container_title MMWR Morbidity and Mortality Weekly Report
description
discipline_display Social Sciences
discipline_facet Social Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:31991
institution FRELIP
journal_source_facet MMWR Morbidity and Mortality Weekly Report
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
— — — — — Demography and Population Studies
Psychology
Social Sciences
sub_discipline_display Psychology
sub_discipline_facet Psychology
subject_display — — — — — Demography and Population Studies
Psychology
Social Sciences
— — — — — Demography and Population Studies
Psychology
Social Sciences
subject_facet — — — — — Demography and Population Studies
Psychology
Social Sciences
title Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_auth Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_full Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_fullStr Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_full_unstemmed Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_short Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
title_sort use of jynneos (smallpox and mpox vaccine, live, nonreplicating) for persons aged ≥18 years at risk for mpox during an mpox outbreak: recommendations of the advisory committee on immunization practices - united states, 2023
topic — — — — — Demography and Population Studies
Psychology
Social Sciences
url https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=759757